RD

Raghuraman Dandapani

Active Director Director DIN 01111964
DIN 01111964 First appointment Jul 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 6 historical roles
Total affiliations 9 Since Jul 2005
Shareholding value •••• Premium profile

About Raghuraman Dandapani

Data last updated:

Raghuraman Dandapani is a Director at Apisun Exim Private Limited (since 2015), Designated Partner at Husiru Business Solutions Llp (since 2022) and Designated Partner at Jayraghu Associates Llp (since 2015). The companies operate in Pharma, Business Services and Construction. The largest current company by reported revenue is Apisun Exim Private Limited at ₹10 Lakh (FY 2025). Earlier, Raghuraman Dandapani was a Director at Richmond Biosciences Private Limited (2007–2015) and Director at Richmond Vivek Laboratories Private Limited (2006–2015) and 4 more.

DIN 01111964
Primary Designation Director
Industry Pharma
First Appointment 21 Jul 2005
Oldest Company Age 14 yrs
Largest company Apisun Exim Private Limited · ₹10 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Apisun Exim Private Limited U74900TG2013PTC087889
Director08 Jan 20152013₹10 Lakh (FY 2025)Active
Designated Partner17 Feb 20222022Active
Designated Partner19 Aug 20152015Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Richmond Biosciences Private Limited U24110TG1989PTC009623
Director21 Feb 20071989₹8.3 Lakh (FY 2022)Active
Director09 Aug 20062006Active
Director21 Jul 20052005Strike Off
Whole-Time Director06 Dec 20162016Active
Whole-Time Director30 Jan 20172013Strike Off
Director15 May 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Raghuraman Dandapani

NameDINCompanyDesignation
Kanagan Jeganathan10589481Apisun Exim Private LimitedAdditional Director
Anuradha09509077Husiru Business Solutions LlpDesignated Partner
Jayanthi Raghuraman01180671Jayraghu Associates LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Samrudhi Life Sciences Private Limited
Richmond Vivek Pharmaceuticals Private Limited
Apisun Exim Private Limited
Husiru Business Solutions Llp
Premium access

Shareholding and investment profile for Raghuraman Dandapani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raghuraman Dandapani

Raghuraman Dandapani currently holds 3 directorships: Apisun Exim Private Limited (Director, since 08 Jan 2015, revenue ₹10 Lakh (FY 2025)); Husiru Business Solutions Llp (Designated Partner, since 17 Feb 2022); Jayraghu Associates Llp (Designated Partner, since 19 Aug 2015).

Raghuraman Dandapani was first appointed on 21 Jul 2005 as Director at Richmond Chemical (India) Private Limited. The most recent appointment on record is 17 Feb 2022 at Husiru Business Solutions Llp.

Raghuraman Dandapani held 6 earlier board appointments: Richmond Biosciences Private Limited (Director, 21 Feb 2007 to 26 Jun 2015); Richmond Vivek Laboratories Private Limited (Director, 09 Aug 2006 to 26 Jun 2015); Richmond Chemical (India) Private Limited (Director, 21 Jul 2005 to 26 Jun 2015); Synovagen Life Sciences Private Limited (Whole-Time Director, 06 Dec 2016 to 13 Apr 2018); Samrudhi Life Sciences Private Limited (Whole-Time Director, from 30 Jan 2017); and 1 more.

The current boards of Raghuraman Dandapani's companies include Kanagan Jeganathan (Apisun Exim Private Limited), Anuradha (Husiru Business Solutions Llp), Jayanthi Raghuraman (Jayraghu Associates Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available